McKesson (NYSE: MCK) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q4), McKesson missed estimates on revenues and whiffed on earnings per share.

Compared to the prior-year quarter, revenue contracted. Non-GAAP earnings per share shrank significantly. GAAP earnings per share dropped significantly.

Gross margins grew, operating margins were steady, net margins contracted.

Revenue details
 McKesson logged revenue of $30.62 billion. The 13 analysts polled by S&P Capital IQ expected a top line of $32.01 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.45. The 16 earnings estimates compiled by S&P Capital IQ averaged $2.30 per share. Non-GAAP EPS of $1.45 for Q4 were 31% lower than the prior-year quarter's $2.09 per share. GAAP EPS of $1.10 for Q4 were 47% lower than the prior-year quarter's $2.08 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 6.5%, 70 basis points better than the prior-year quarter. Operating margin was 2.1%, much about the same as the prior-year quarter. Net margin was 0.8%, 80 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $32.62 billion. On the bottom line, the average EPS estimate is $1.66.

Next year's average estimate for revenue is $131.25 billion. The average EPS estimate is $8.01.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 617 members out of 644 rating the stock outperform, and 27 members rating it underperform. Among 221 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 213 give McKesson a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $117.23.

Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.